Myriad, Rival Strike Deal In Cancer-Test Patent Dispute

By Jeff Sistrunk (February 7, 2014, 3:43 PM EST) -- Myriad Genetics Inc. has settled its suit against Gene by Gene Ltd. over alleged infringement of its cancer-testing patents, including several that were upheld in a landmark U.S. Supreme Court decision last year, with Gene by Gene agreeing to stop offering the tests in North America, the companies said Friday....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!